Segall Bryant & Hamill’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CB
Segall Bryant & Hamill's CNMD Position: Q1 2026 in Review
Segall Bryant & Hamill sold out of CONMED (CNMD) in Q1 2026, closing a stake of 41,558 shares — an estimated $1.69M sold.
Segall Bryant & Hamill first reported a position in CNMD in Q1 2020 and held it in 19 quarters. The position peaked at $11.2M in Q4 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Segall Bryant & Hamill reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Segall Bryant & Hamill sold 41,558 CONMED shares in Q1 2026, an estimated $1.69M.
- Segall Bryant & Hamill first reported a position in CONMED in Q1 2020 and held it in 19 quarters.
- Segall Bryant & Hamill's CONMED position peaked at $11.2M in Q4 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.